FinRadar.ai

🧵 1/ The deadline for institutional reporting is TODAY. -Track every fund's holdings -Find the changes in their positions -Get your notifications/alerts set up -Filter the best performers on the quarter, and over time -Dive deep in the details of every fund -Create your own baskets of funds... ALL IN ONE PLACE. DETAILS BELOW finradar.ai/hedge-fund-ana…

Took a look at the most recent 13F aggregated data for Q1 2026 to find where funds are loading aggressively on any of these: 🟢 $GPN +$3.81B | +30.7% share chg 🟢 $XYZ +$2.16B | +10.4% share chg 🟢 $NKE +$2.14B | +4.9% share chg 🟢 $MRNA +$1.86B | +14.8% share chg 🟢 $ALGN +$1.47B | +15.6% share chg 🟢 $CSGP +$1.49B | +11.6% share chg 🟢 $SWK +$867M | +10.3% share chg 🟢 $CAG +$760M | +15.0% share chg 🟢 $EPAM +$789M | +13.1% share chg 🟢 $CHTR +$804M | +4.4% share chg 🟢 $CPB +$439M | +13.2% share chg 🟢 $POOL +$438M | +6.8% share chg 🟢 $LULU +$423M | +3.9% share chg 🟢 $PSKY +$461M | +20.0% share chg 🟢 $ARE +$304M | +5.4% share chg 🟢 $BAX +$251M | +3.2% share chg 🔴 $PYPL -$681M | -2.6% share chg ← only major outflow

Here are the top 20 worst performing stocks in the S&P 500 over the last 5 years 💩PayPal $PYPL 🔴 -81.97% Charter $CHTR 🔴 -80.25% EPAM Systems $EPAM 🔴 -79.40% Baxter $BAX 🔴 -79.37% Paramount Skydance $PSKY 🔴 -74.58% Alexandria Real Estate $ARE 🔴 -73.69% Estee Lauder $EL 🔴 -72.92% Align $ALGN 🔴 -72.37% Fidelity National $FIS 🔴 -72.13% Moderna $MRNA 🔴 -69.61% Nike $NKE 🔴 -69.19% Xylem $XYZ 🔴 -66.15% Global Payments $GPN 🔴 -66.03% Brown-Forman $BF-B 🔴 -65.82% Stanley Black & Decker $SWK 🔴 -65.21% Conagra $CAG 🔴 -64.24% Lululemon $LULU 🔴 -62.14% CoStar $CSGP 🔴 -60.24% Pool Corp $POOL 🔴 -59.95% Campbell's $CPB 🔴 -59.39%

For the funds that have reported so far, $HIMS is seeing a net outflow of $579M in Q1 2026

Good job! careful as many funds report their positions /1000 sometimes, and that can ruin your math or silently generate flaws in the data. Also sometimes a company CUSIP will change, you would see that the fund closed a position (untrue). Also careful with stock splits/reverse splits, they will mess the data... A very few of the nightmares I had when I coded my platform. Fun to have though!

I just asked my new AI Stock Market assistant to create me a custom dashboard for the 13F filings - Berkshire Hathaway's $10 Billion buy of Google $GOOGL stock was the biggest $$$ move made - 8 out of the 10 biggest dollar moves made during the quarter were sales - Google and Nvidia $NVDA stocks were the most held by the funds tracked What should I have the AI add to make it more valuable?

@MikeLongTerm @BlackRock @PalantirTech Funds did load up on $PLTR in Q1 2026 with + 20+ Billion $ in net fund flows

BREAKING $PLTR HOLY SHIT! @BlackRock 🚀🚀🚀 13F Filing- Blackrock ($14 Trillion AUM) Bought Call contracts and have 188,990,971 shares on @PalantirTech (link below)

@SJosephBurns @grok Thought this would be of interest to you Steve. We aggregate all 8.5K+ institutions as they come. Also, this is where $MU for example stands. x.com/StuckInStock/s…

Hey @grok Analyze the recent billionaire 13F filings in May 2026. Which stocks are these whales quietly loading up the most on based on these new reports? Top 3 tickers.

Some of the healthcare stocks with the heaviest institutional loading based on total share increases, $ flows, $ flow relative to the market cap (from all filers) $TENX $NKTR $DRUG $ALXO $ SABS $ WAT $AVTX Full list on the website for every sector or industry

BAKER BROS. ADVISORS — Q1 2026 13F BREAKDOWN
Pure-play biotech fund | $17.1B portfolio ---  HIGHEST CONVICTION ADDS $PRAX +63.4% — Praxis Precision Medicine. Biggest add of the quarter. CNS/epilepsy precision therapy  $KYMR +30.2% — Kymera Therapeutics. Targeted protein degradation. Novel mechanism accumulation $GRAL +27.9% — GRAIL Inc. Multi-cancer early detection. Liquid biopsy thesis building $ALKS +23.7% — Alkermes. CNS + addiction medicine. Undervalued pharma getting a Baker look $KOD +15.1% — Kodiak Sciences. Retinal disease. Quiet but meaningful add $SMMT +7.9% — Summit Therapeutics. RAS/oncology pipeline momentum ---  TRIMS (Disciplined Reduction) $INSM -1.65% — Minor trim on Insmed. Still #4 at $1.15B. Locking in gains, not exiting $EWTX -10.0% — Edgewise Therapeutics. Cardiac/musculoskeletal. Only notable trim beyond $INSM ---  MEGA HOLDS (Unchanged, Full Conviction) $INCY — #1 position, $3.04B, 17.8% of portfolio. Unwavering $ONC — #2, $2.67B, 15.7%. BeOne Medicines ADR. Rock solid $MDGL — #3, $1.25B. Madrigal Pharma. NASH/metabolic liver disease $ACAD — #5, $1.15B. ACADIA Pharma. CNS neuroscience $CELC — #6, $790M. Celcuity oncology $RVMD — #7, $753M. Revolution Medicines RAS inhibitor $RYTM — #10, $600M. Rhythm Pharma. Unchanged — metabolic rare disease ---  THE THEMES:  CNS Dominance — $PRAX $ALKS $ACAD = Baker is doubling down on brain  Novel Mechanisms — $KYMR (protein degradation) + $RVMD (RAS) = cutting-edge science bets  Early Detection — $GRAL liquid biopsy quietly growing  Retinal/Rare Disease — $KOD $RYTM $INSM = durable rare disease exposure  Mature Oncology Core — $INCY $ONC $MDGL anchor the book with proven commercial assets --- Bottom line: Baker Bros is adding precision CNS + novel mechanism platforms while trimming at the margins. The core $INCY $ONC $MDGL $ACAD block is UNTOUCHED — full conviction on the blue-chip biotech backbone. $PRAX and $KYMR are the clearest new-quarter bets. 

ELLIOTT INVESTMENT MGMT | Q1 2026 | $20.1B Portfolio
19 positions. Hyper-concentrated. Paul Singer  ---  NEW POSITIONS $NCLH (Norwegian Cruise Line) — $247M, 1.55% of book. Fresh activist target?  $RIG (Transocean) — $104M, 0.65%. Offshore drilling conviction play. ---  INCREASED $HPE +47% → added 8.8M shares → now $653M (4.1%). Massive enterprise tech bet  $HDB (HDFC Bank) +268% → nearly tripled. EM banking sleeper pick  $SDRL +3.5% → small add, consistent energy thesis ---  DECREASED $LUV -40.7% → shed 20.8M shares → down to $1.14B (7.2%). Activist campaign winding DOWN  $MSTR bonds -37.5% → cutting crypto-adjacent debt exposure  $TFPM -0.4% → tiny trim, still the #1 holding at 29% of book ---  CLOSED COMPLETELY $HYG — high-yield ETF hedge? Gone. $BILL — exited fintech $ST (Sensata Tech) — out $FSK (FS KKR) — dumped credit ---  THE THEMES:  Energy dominance — $PSX + $SU + $RIG + $SDRL = ~46% of book. Elliott = energy fund now  Hard assets — $TFPM still 29%. Gold royalty as macro hedge isn't going anywhere  $LUV exit watch — down 40% this quarter. The Southwest activist play is closing  Enterprise tech re-rate — $HPE nearly doubled. Undervalued hardware thesis  Dumping credit — closed $HYG + $FSK. Risk-off on fixed income --- Bottom line: Elliott is a concentrated Energy + Hard Assets machine with selective activist unwinds.

ICAHN Q4 2025 13F BREAKDOWN — $8.55B portfolio, 12 positions --- PORTFOLIO CONCENTRATION 77.4% Energy. Top 3 holdings ($IEP + $CVI + $UAN) = 82.7% of the book --- MAJOR MOVES INCREASED (2) $CVI +1.1% (added 783K shares) — doubling down on his own refiner. Now 28% of portfolio. $2.4B position. $SD +0.7% (added 36K shares) — small but consistent accumulation in SandRidge Energy DECREASED (1) $SATS -58.1% (cut 1.95M shares) — massive trim on EchoStar. Was a merger arb play after the DISH deal fell through. Icahn is walking away. CLOSED (1) $SWX GONE — exited Southwest Gas Holdings entirely. The activist campaign there ran its course. He got what he wanted, he's out. --- THE THEMES ENERGY CONSOLIDATION — $CVI, $UAN, $SD all held or added. Icahn is leaning harder into energy as a macro theme heading into 2025. ACTIVIST EXITS — $SWX closed, $SATS slashed. FORTRESS CORE — $IFF, $AEP, $JBLU, $CTRI, $CZR, $BLCO all unchanged. He's not rotating — he's holding and waiting. --- BOTTOM LINE Icahn cleaned house on two activist plays ($SWX, $SATS) and poured the proceeds back into energy. Pure conviction positioning. 77% energy exposure is a bold macro call.

PERSHING SQUARE CAPITAL MANAGEMENT, L.P. - TOP 10 HOLDINGS New position in $MSFT , Increased position in AMZN Q: 2026-03-31 via finradar.ai/hedge-fund-ana…

Perceptive Advisors ($5.1B portfolio) — Q1 2026 13F Breakdown Pure-play biotech fund. 99.5% Healthcare. Here's what they did --- CONVICTION ADDS (Massive increases) $RLAY +412% — Relay Therapeutics, added 7.8M shares. Huge bet on precision oncology pipeline $SABS +701% — SAB Biotherapeutics, added 5.6M shares. Deep immunology play $CRVS +231% — Corvus Pharma, tripled position. Cancer immunotherapy $TENX +230% — Tenax Therapeutics, added 1M shares $BCRX +135% — BioCryst, added 4.3M shares. Rare disease/plasma protein disorders $CNTA +80% — Centessa Pharma, added 2.3M shares. Now a 4.1% position --- 18 NEW POSITIONS — Key names: $IONS · $DAWN · $RVMD · $DMRA · $DBVT · $STRO Theme: RNA/antisense therapy + emerging oncology platforms --- CLOSED 38 POSITIONS — Notable exits: $EXAS · $ACLX · $BSX · $DHR · $FOLD · $PEN Theme: Dumping large/mega-cap healthcare & diagnostics. Rotating into small-cap biotech --- TRIMMED HARD: $APGE -34% — Cut Apogee Therapeutics by 790K shares $NBIX -80% — Nearly exited Neurocrine $VRDN -62% — Slashed Viridian Therapeutics $OMDA -67% — Omada Health gutted --- 📷 The Big Theme: Perceptive is de-risking large-cap/commercial-stage biopharma and doubling down on early/mid-stage clinical-stage biotech — particularly rare disease, oncology precision medicine, and gene therapy ($MGTX, $SLDB, $DYN all held or added).

$NVDA 13F filing is out: finradar.ai/filer/nvidia-c…

📷 BREAKING: Buffett's Berkshire Q1 2026 13F — The Full Move Breakdown $BRK.B | $263B Portfolio --- NEW POSITIONS (3 buys) • $DAL — Delta Air Lines, $2.6B | 39.8M shares — Big transport bet • $GOOG — Alphabet Class C, $1B | adds to existing $GOOGL stake • $M — Macy's, $55M | tiny starter --- INCREASED (4 adds) • $GOOGL — +204% 📷 Tripled the stake to 54M shares, now 5.9% of portfolio • $NYT — +199% Nearly tripled. Media contrarian play? • $LEN — +43% Lennar homebuilder bet growing --- DECREASED (6 trims) • $STZ — Constellation Brands NEARLY EXITED. -95% 📷 (1.2M shares dumped) • $NUE — Nucor steel -39% • $CVX — Chevron -35% (sold 45.8M shares — massive exit from Big Oil) • $DVA — DaVita -5% • $BAC — BofA trimmed again -0.7% --- CLOSED (16 exits!) — The biggest exits: $V · $MA · $UNH · $AMZN · $DPZ · $AON · $CHTR · $POOL --- 📷 THE THEMES: Big Tech pivot — Tripling $GOOGL while dumping $V & $MA signals a shift from payments to AI/search Ditching fossil fuels — $CVX -35%, energy allocation still high via $OXY but Big Oil is out Consumer pullback — $STZ near-exit, $DPZ closed, $UNH closed = reducing cyclical/consumer exposure Media conviction — $DAL + $NYT are bold contrarian calls in beaten-down sectors --- Core stays rock solid: $AAPL (22%), $AXP (17%), $KO (12%), $OXY — Buffett's "forever" holds untouched 📷

Here's Lone Pine Capital's latest 13F breakdown 🧵👇 --- ⚡ THEME 1: ALL-IN ON POWER & ENERGY Lone Pine is making a massive bet on the energy supercycle — especially power gen tied to AI/data centers. $VST (Vistra) +19% → #1 position at 7.4% of portfolio $TLN (Talen Energy) +41% → $580M position $WULF (TeraWulf) 🆕 $287M — Bitcoin mining + power infra $HUT (Hut 8) 🆕 $285M — same play $AGX (Argan) 🆕 $214M — power plant construction --- 🤖 THEME 2: TECH CONVICTION, BUT SELECTIVE $APP (AppLovin) nearly DOUBLED (+88%) → $583M $TER (Teradyne) 🆕 $555M — semis/robotics $ASML +8% → $865M, still the 2nd largest holding $CIEN (Ciena) 🆕 $314M — optical networking BUT... $TSM cut by 54% 😬 --- 🏥 THEME 3: HEALTHCARE ROTATION IN $THC (Tenet Healthcare) +26% $MCK (McKesson) 🆕 $339M Healthcare now = 10.3% of portfolio --- 🍔 THEME 4: DEFENSIVE CONSUMER/INFRA ADDED $USFD (US Foods) 🆕 $350M $PFGC (Performance Food) 🆕 $341M $GLW (Corning) 🆕 $506M $MTZ (MasTec) 🆕 $493M — infrastructure buildout --- 🚪 THEME 5: BIG EXITS — MEGA CAP TECH PURGE Lone Pine dumped the consensus longs: $MSFT ❌ CLOSED $AMZN ❌ CLOSED $AVGO ❌ CLOSED $KKR cut 96% 😳 $APH cut 92% --- TL;DR 🎯 Lone Pine is rotating OUT of mega-cap tech & private equity into power infrastructure, AI-adjacent plays, healthcare, and food distribution. The energy + data center power theme is their #1 conviction. Fascinating pivot for a $12.5B book. 👀 via finradar.ai/filer/lone-pin…

LONE PINE CAPITAL LLC - NEW POSITIONS Q: 2026-03-31 via finradar.ai/filer/lone-pin…

📷 Portfolio Overview Total Value: $5.93B | 31 holdings Filing Date: Q1 2026 --- 📷 Theme 1: Big Tech Mega-Concentration Tepper doubled down on cloud/AI infrastructure anchors: $AMZN — Top holding at 15.2% of portfolio, shares +98% (+2.14M shares) → ~$900M position $MU — 9.5% weight, shares +11% → $563M $TSM — 7.6% weight, +17.5% → $449M $NVDA — Trimmed -13.4% but still held at $257M (4.3%) $SNDK (SanDisk) — New position, $179M (3.0% of portfolio) — fresh bet on flash storage > Signal: Tepper is concentrating in memory, foundry, and cloud — a conviction play on AI infrastructure buildout. --- 📷 Theme 2: Ride-Sharing Conviction — Explosive Entry $UBER — Shares +242% (+4.48M shares) to 7.7% of portfolio ($456M) — one of the most aggressive moves in the book $LYFT — Trimmed -29% (~$36M remaining) > Tepper is going all-in on Uber while scaling back Lyft — a clear winner-take-most thesis in ride-hailing. --- 📷 Theme 3: Power / Energy Surge $VST (Vistra) — +114% → $304M (5.1%) $NRG — +5.8% → $253M (4.3%) Combined, energy/utilities represent ~9.4% of the portfolio > Data center power demand is the underlying driver. Tepper is aligning this with his AI infrastructure bet. --- 📷 Theme 4: China De-Risking Major trimming across China names: $BABA — -32.6% (-1.67M shares), still $435M but clearly reducing $PDD — -49.3% → $92M $JD — -68.6% → $39M $KWEB (ETF) — Cut -77.3% $BIDU — Bucked the trend, +20.4% (selective conviction) > China exposure is being systematically unwound — except Baidu, where Tepper may be playing the AI angle. --- 📷 Exits (8 Positions Closed) All 3 major airlines were fully exited — $AAL, $UAL, $DAL — plus $IQV, $MHK, $OC, $GT, and $FXI. A clean sweep of cyclical/travel exposure. --- Summary Scorecard | Theme | Direction | |---|---| | AI Infrastructure (Cloud/Memory/Chips) | 📷 Strong Buy | | Ride-Sharing ($UBER) | 📷 Aggressive Add | | Power/Energy ($VST, $NRG) | 📷 Accumulating | | China Equities | 📷 Reducing | | Airlines / Travel | 📷 Full Exit |

Appaloosa LP - INCREASES (SORTED BY %) Q: 2026-03-31 via finradar.ai/filer/appaloos…

📷 MAJOR HEADLINE THEMES FROM DUQUESNE (STANLEY DRUCKENILLER) 13F Filing finradar.ai/filer/duquesne… 1. BIOTECH CONVICTION PLAY Natera ( $NTRA ) becomes a 21% portfolio bet — their largest position (20.86%), despite trimming slightly (-21.87%). Heavy biotech allocation (41.7% of portfolio) signals confidence in genetic testing/diagnostics. Added new biotech names: Caris Life Sciences ($CAI), Revolution Medicines ($RVMD). --- 2. MASSIVE SECTOR ROTATION OUT OF MEGA-CAP TECH Exited almost entirely: $AMZN (-93.79%), $GOOG (-100% closed), Alphabet (closed). Sold Meta entirely ($55.9M), $NVDA , $AMD (closed). This signals value/cyclical over growth momentum. --- 3. EMERGING MARKETS / ARGENTINA MACRO BET $YPF added with massive conviction — +433% increase ($149.6M position). Added Brazil ETF ($EWZ), $ARGT (Argentina ETF). Clear bet on commodities/LatAm recovery, possibly inflation hedge against peso strength. --- 4. SEMICONDUCTOR RESHUFFLING Cut $TSM heavily (-29.02%), Lattice LSCC (-65.1%), ON Semi (closed) Added Broadcom ($AVGO) as new $60.6M position → suggests betting on data center/AI infrastructure over commodity chip exposure --- 5. FINTECH/PAYMENTS PURGE Closed entirely: Stripe competitor $TWLO ($51.3M), Docusign ($69.7M partial). Cut Coupang (-60.62%), $QSR (-62.41%), StubHub (-45.87%) — exiting high-growth consumer/soft goods. --- 6. HEALTHCARE CONSOLIDATION Held $INSM (-22.11% trim, still $257.8M), $NAMS (held flat at $98.3M) Cut $TEVA heavily (-59.53%), but added Humana, Option Care Health ($OPCH) → Rotating from biopharma pain toward healthcare services --- 7. INDUSTRIAL & COMMODITIES DOUBLING DOWN Woodward ($WWD): Cut -64.23%, but still $178.6M (core holding) Alcoa ($AA): +8.53% increase $STMI STMicroelectronics: +237.78% (major add of $1.8M shares) → betting on industrial semiconductors, aerospace, energy Added $CRH (building materials) partially --- 8. CHINA PIVOT $CPNG: Cut -60.62% from $125M → exiting China-adjacent Sea Limited: Modest increase despite volatility $ROKU: +28.68% increase (streaming, less China-dependent) --- OVERALL PORTFOLIO SHIFT | Metric | Direction | |--------|-----------| | Closed positions | 30 holdings (major tech exit) | | New positions | 30 holdings (small-cap value/commodities) | | Decreased | 18 holdings | | Increased | 12 holdings | | Sector tilt | 41.7% Healthcare (from growth angle) + 18.9% Tech (semiconductors) | --- THE INVESTMENT THESIS Druckenmiller is clearly rotating hard from mega-cap tech growth into: (1) biotech/healthcare, (2) commodities/LatAm inflation plays, (3) semiconductor infrastructure, and (4) industrial hard assets. This screams stagflation/inflation hedge with conviction in Natera as his flagship idea while trimming proven winners (Amazon, Google) ahead of potential economic headwinds.